Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects. [electronic resource]
Producer: 20200727Description: e14199 p. digitalISSN:- 2051-817X
- Adult
- Anti-Bacterial Agents -- pharmacology
- Dietary Fats -- adverse effects
- Gastrointestinal Microbiome -- drug effects
- Humans
- Inflammation -- metabolism
- Lipopolysaccharides -- blood
- Male
- Metabolic Syndrome -- metabolism
- Middle Aged
- Monocytes -- drug effects
- Obesity -- metabolism
- Postprandial Period -- drug effects
- Vancomycin -- pharmacology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.